In vivo, oral administration of L. crispatus (108 CFU) daily for 2 weeks followed by twice-weekly for 12 weeks significantly reduced hepatic steatosis, improved insulin sensitivity and cardiac function in a diet-induced cardiometabolic disorder mouse model. This evidence concerns the gene INS and fatty liver disease.